Over the past few years, due to both appropriate and inappropriate use, the demand for and use of GLP-1 and GIP/GLP-1 receptor agonists have increased substantially, leaving drug manufacturers struggling to keep their supply sufficient to meet these increased needs
Converting doses to syringe units This is where many researchers make critical errors
IV Therapy Visceral fat or recovery is holding me back Purpose-built drips to support recovery, energy, and wellness
Added sugars drive nutrient and energy deficit in obesity: a new paradigm
All NPs must have a Prescriptive Authority Agreement (PAA) with a Texas-licensed physician that explicitly covers weight-loss medications
When the body experiences stress, the digestive systems functioning is affected, leading to a CVS episode